Neuberger Berman Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $90.8M | Sell |
2,126,406
-4,946,488
| -70% | -$269M | 0.06% | 371 |
|
|
2026
Q1 | $444M | Buy |
7,072,894
+3,062,633
| +76% | +$245M | 0.34% | 54 |
|
|
2025
Q4 | $382M | Buy |
4,010,261
+21,798
| +0.5% | +$2.14M | 0.28% | 65 |
|
|
2025
Q3 | $389M | Buy |
3,988,463
+27,248
| +0.7% | +$2.82M | 0.28% | 69 |
|
|
2025
Q2 | $425M | Buy |
3,961,215
+44,274
| +1% | +$4.48M | 0.33% | 57 |
|
|
2025
Q1 | $395M | Sell |
3,916,941
-104,504
| -3% | -$10.5M | 0.33% | 63 |
|
|
2024
Q4 | $359M | Buy |
4,021,445
+10,696
| +0.3% | +$942K | 0.29% | 72 |
|
|
2024
Q3 | $336M | Sell |
4,010,749
-23,535
| -0.6% | -$1.86M | 0.26% | 90 |
|
|
2024
Q2 | $311M | Buy |
4,034,284
+110,953
| +3% | +$8.12M | 0.26% | 90 |
|
|
2024
Q1 | $269M | Sell |
3,923,331
-189,359
| -5% | -$12.2M | 0.22% | 114 |
|
|
2023
Q4 | $238M | Sell |
4,112,690
-2,600,200
| -39% | -$139M | 0.21% | 127 |
|
|
2023
Q3 | $354M | Sell |
6,712,890
-3,174,216
| -32% | -$166M | 0.32% | 69 |
|
|
2023
Q2 | $534M | Buy |
9,887,106
+582,217
| +6% | +$30.4M | 0.48% | 39 |
|
|
2023
Q1 | $465M | Buy |
9,304,889
+5,068,740
| +120% | +$239M | 0.43% | 46 |
|
|
2022
Q4 | $196M | Buy |
4,236,149
+462,891
| +12% | +$20M | 0.19% | 146 |
|
|
2022
Q3 | $146M | Sell |
3,773,258
-1,980,774
| -34% | -$79.5M | 0.15% | 187 |
|
|
2022
Q2 | $214M | Buy |
5,754,032
+527,172
| +10% | +$21.5M | 0.22% | 129 |
|
|
2022
Q1 | $231M | Buy |
5,226,860
+1,076,827
| +26% | +$46.7M | 0.2% | 136 |
|
|
2021
Q4 | $176M | Sell |
4,150,033
-242,190
| -6% | -$10.2M | 0.14% | 214 |
|
|
2021
Q3 | $190M | Sell |
4,392,223
-1,759,003
| -29% | -$77.8M | 0.17% | 178 |
|
|
2021
Q2 | $263M | Sell |
6,151,226
-150,719
| -2% | -$6.34M | 0.23% | 112 |
|
|
2021
Q1 | $243M | Buy |
6,301,945
+2,380,532
| +61% | +$90.1M | 0.23% | 118 |
|
|
2020
Q4 | $141M | Buy |
3,921,413
+845,723
| +27% | +$30.5M | 0.15% | 205 |
|
|
2020
Q3 | $117M | Sell |
3,075,690
-288,005
| -9% | -$11.1M | 0.14% | 212 |
|
|
2020
Q2 | $118M | Sell |
3,363,695
-22,775
| -0.7% | -$820K | 0.15% | 189 |
|
|
2020
Q1 | $111M | Sell |
3,386,470
-2,296,224
| -40% | -$89.7M | 0.17% | 167 |
|
|
2019
Q4 | $257M | Sell |
5,682,694
-73,532
| -1% | -$3.08M | 0.3% | 82 |
|
|
2019
Q3 | $234M | Sell |
5,756,226
-54,084
| -0.9% | -$2.29M | 0.29% | 94 |
|
|
2019
Q2 | $250M | Buy |
5,810,310
+366,086
| +7% | +$14.1M | 0.3% | 85 |
|
|
2019
Q1 | $209M | Sell |
5,444,224
-490,866
| -8% | -$18.7M | 0.26% | 101 |
|
|
2018
Q4 | $210M | Sell |
5,935,090
-266,175
| -4% | -$9.65M | 0.29% | 77 |
|
|
2018
Q3 | $239M | Sell |
6,201,265
-38,900
| -0.6% | -$1.36M | 0.27% | 92 |
|
|
2018
Q2 | $204M | Sell |
6,240,165
-74,861
| -1% | -$2.26M | 0.23% | 126 |
|
|
2018
Q1 | $173M | Buy |
6,315,026
+346,549
| +6% | +$9.42M | 0.2% | 154 |
|
|
2017
Q4 | $148M | Buy |
5,968,477
+3,614,307
| +154% | +$99.7M | 0.17% | 192 |
|
|
2017
Q3 | $68.7M | Sell |
2,354,170
-45,522
| -2% | -$1.26M | 0.09% | 322 |
|
|
2017
Q2 | $66.5M | Sell |
2,399,692
-49,169
| -2% | -$1.3M | 0.09% | 330 |
|
|
2017
Q1 | $60.9M | Sell |
2,448,861
-253,751
| -9% | -$6.17M | 0.08% | 350 |
|
|
2016
Q4 | $58.5M | Buy |
2,702,612
+1,034,693
| +62% | +$22.6M | 0.08% | 353 |
|
|
2016
Q3 | $39.7M | Sell |
1,667,919
-79,809
| -5% | -$1.9M | 0.05% | 433 |
|
|
2016
Q2 | $40.8M | Buy |
1,747,728
+114,583
| +7% | +$2.48M | 0.06% | 412 |
|
|
2016
Q1 | $30.7M | Buy |
1,633,145
+1,612,913
| +7,972% | +$28.3M | 0.04% | 473 |
|
|
2015
Q4 | $373K | Sell |
20,232
-23,131
| -53% | -$414K | ﹤0.01% | 1346 |
|
|
2015
Q3 | $712K | Sell |
43,363
-12,754
| -23% | -$218K | ﹤0.01% | 1227 |
|
|
2015
Q2 | $993K | Buy |
56,117
+19,668
| +54% | +$351K | ﹤0.01% | 1211 |
|
|
2015
Q1 | $647K | Buy |
36,449
+4,141
| +13% | +$65.4K | ﹤0.01% | 1295 |
|
|
2014
Q4 | $428K | Sell |
32,308
-1,361,909
| -98% | -$17.4M | ﹤0.01% | 1382 |
|
|
2014
Q3 | $16.5M | Sell |
1,394,217
-413,559
| -23% | -$5.21M | 0.02% | 728 |
|
|
2014
Q2 | $23.1M | Sell |
1,807,776
-513,061
| -22% | -$6.67M | 0.02% | 625 |
|
|
2014
Q1 | $31.4M | Sell |
2,320,837
-16,268
| -0.7% | -$214K | 0.03% | 528 |
|
|
2013
Q4 | $28.1M | Buy |
2,337,105
+56,860
| +2% | +$672K | 0.03% | 545 |
|
|
2013
Q3 | $26.8M | Sell |
2,280,245
-180,430
| -7% | -$1.95M | 0.03% | 552 |
|
|
2013
Q2 | $22.8M | Buy |
+2,460,675
| New | +$20.9M | 0.03% | 567 |
|
Other funds holding BSX
Neuberger Berman Group's BSX Position: Q2 2026 in Review
Neuberger Berman Group reduced its Boston Scientific (BSX) stake by 70% in Q2 2026, selling an estimated $269M and leaving 2,126,406 shares worth $90.8M. The position accounts for 0.06% of the portfolio, ranked #371.
Neuberger Berman Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $534M in Q2 2023. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Neuberger Berman Group held 2,126,406 shares of Boston Scientific worth $90.8M as of Q2 2026.
- Neuberger Berman Group sold 4,946,488 Boston Scientific shares in Q2 2026, an estimated $269M.
- Boston Scientific made up 0.06% of Neuberger Berman Group's portfolio in Q2 2026, its #371 holding.
- Neuberger Berman Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Neuberger Berman Group's Boston Scientific position peaked at $534M in Q2 2023.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.